Moderna receives USFDA approval for Covid-19 vaccine ‘Spikevax’
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The company’s largest center for medical device applications, serving the entire Asian market
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
To streamline complex medical writing workflows with GenAI
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Subscribe To Our Newsletter & Stay Updated